Latest news
Amylyx Pharmaceuticals (AMLX) Could Be 5% Undervalued After Second Quarter Earnings - simplywall.stsimplywall.st · Fri, 07 Aug 2026 20:15:49 GMTAmylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026 - PluangPluang · Fri, 07 Aug 2026 15:53:04 GMTAmylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 15:48:02 GMTAmylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:28:15 GMTAmylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 03:43:34 GMTAmylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $26.7, Implies 22% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:04 GMTAmylyx Pharmaceuticals Narrows Q2 2026 Loss to -$0.39/Share - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 19:46:42 GMTAmylyx Pharmaceuticals Inc (AMLX) (Q2 2026) Earnings Call Highlights: Advancing Toward Pivotal ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 19:01:28 GMT